viral kinetic

Related by string. viral kinetics * VIRAL . Virals . virals . Viral : undetectable viral load . viral load . inhibit viral replication . viral loads . viral infection . viral infections . contagious viral infection / kinetics . KineticD . KINETIC . Kinetics . Kinetic : Kinetic Concepts Inc. . Kinetic Concepts . kinetic sculpture . kinetic sculptures . Cavendish Kinetics . kinetic warhead * *

Related by context. Frequent words. (Click for all words.) 71 phase IIb 69 Phase 2a trial 68 unblinded 68 Phase 2b study 68 Phase 1b 68 Phase Ib 67 Phase 2b clinical 67 Phase 2a clinical 66 multiple ascending dose 65 dose escalation 65 Phase IIa trial 65 dose escalation trial 65 elagolix 65 Phase IIa clinical 64 Phase 2a 64 placebo controlled 64 CoFactor 63 HGS ETR1 63 pivotal Phase III 63 Phase III clinical 63 Phase IIb clinical 63 DSMB 63 pharmacodynamic 63 dose escalation study 63 pharmacodynamics 62 tolerability profile 62 pharmacokinetic 62 randomized controlled clinical 62 ISIS # 62 Phase 2b trial 62 Phase III pivotal 62 randomized Phase 62 CA4P 62 IMGN# 62 confirmatory Phase 3 62 multicenter randomized double 62 placebo controlled trials 62 composite endpoint 61 randomized clinical 61 efficacy endpoints 61 tolerability 61 sunitinib 61 refractory multiple myeloma 60 randomized placebo controlled 60 dosing regimens 60 Phase 2b 60 sapacitabine 60 antiviral activity 60 evaluable patients 60 Phase IIb 60 DURATION 60 IDX# 60 randomized clinical trials 60 pivotal Phase 60 Phase IIb trial 60 blind randomized placebo 60 ZYBRESTAT 60 tolerated dose MTD 60 Secondary endpoints 60 multicenter 60 dose limiting toxicities 59 clinical trial 59 sustained virologic response 59 randomized 59 non inferiority 59 randomized controlled 59 Alpharadin 59 mg dose 59 Phase IIa 59 carfilzomib 59 Azixa 59 metastatic renal cell carcinoma 59 prospective randomized 59 MDV# 59 Phase III trials 59 NGX# 59 single ascending dose 59 BAY #-# 59 INCB# [002] 59 efficacy 58 evaluable 58 GRN#L 58 picoplatin 58 AACR NCI EORTC 58 AP# [003] 58 perifosine 58 secondary endpoint 58 clinically meaningful 58 RG# [001] 58 primary endpoints 58 docetaxel 58 free survival PFS 58 denufosol 58 plus ribavirin 58 LEVADEX 58 bavituximab 58 bosentan 58 Locteron 58 adalimumab 58 mg BID 58 LymphoStat B

Back to home page